Back to Search Start Over

Hydrogen sulfide donors in research and drug development

Authors :
Thilo Hagen
Choon-Hong Tan
Philip K. Moore
Zheng-Wei Lee
Dejian Huang
Zhi Jian Song
Lih-Wen Deng
Weilu Dai
Mei Ying Ng
Source :
Med. Chem. Commun.. 5:557-570
Publication Year :
2014
Publisher :
Royal Society of Chemistry (RSC), 2014.

Abstract

Hydrogen sulfide (H2S) has recently emerged as an important biological gasomediator as a result of numerous insightful studies. The use of H2S releasing compounds has attracted much attention as they can exert crucial effects on a wide range of cellular signaling processes. Some of these effects are potentially exploitable in terms of anti-inflammatory and anti-tumor effects, as well as precise ion-channel regulation, cardiovascular protection and oxidation resistance. Unfortunately, the potential therapeutic effects of H2S are controversial due to conflicting published results regarding its effects on cellular activities arising, perhaps in part, from the use of different H2S donors. Therefore it is essential to review the most commonly used H2S releasing compounds, some of which are currently in clinical trials along with their associated in vitro and/or in vivo biological effects.

Details

ISSN :
20402511 and 20402503
Volume :
5
Database :
OpenAIRE
Journal :
Med. Chem. Commun.
Accession number :
edsair.doi...........00f8b005f8c4240398cb59b229e29adb
Full Text :
https://doi.org/10.1039/c3md00362k